Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]
Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.
-
FDA approval · 2019-05-20FDA Approved: DACTINOMYCIN — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the original (ANDA) application for Dactinomycin from XGen Pharmaceuticals DJB, Inc., establishing a generic version of this ch…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas [Phase 1, Phase 2]
Pilot study investigating expanded, activated haploidentical natural killer cell infusions for Ewing sarcoma and rhabdomyosarcoma across Pha…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiotherapy combined with apatinib mesylate for childhood rhabdomyosarcoma; efficacy and safety data not yet ava…
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Trial of Dasatinib in Advanced Sarcomas [Phase 2]
Phase 2 trial update for dasatinib in advanced sarcomas, with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating haploidentical stem cell transplantation with NK cell therapy in high-risk solid tumors, including neurobl…
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children [Phase 1]
A Phase 1 clinical trial of doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative brachytherapy for unresect…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma [Phase 2]
Open-label Phase 2 study of IMC-A12 (cixutumumab) in advanced sarcomas. Results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating HSV-1716 in patients with non-CNS solid tumors, including rhabdomy…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: A Vaccine Study for High Risk Cancers [Phase 1]
A Phase 1 cancer vaccine study has been withdrawn; it targeted neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
-
FDA approval · 2017-11-09FDA Approved: DACTINOMYCIN — Original Application (Eugia US LLC)
FDA approved the original ANDA for dactinomycin (generic) to Eugia US LLC, enabling generic manufacturing and distribution of this anticance…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma [Phase 2]
A Phase 2 trial evaluated temozolomide in combination with cixutumumab and chemotherapy for metastatic rhabdomyosarcoma; the study has compl…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma [Phase 3]
A Phase 3 clinical trial evaluating the combination of chemotherapy and radiation therapy in newly diagnosed rhabdomyosarcoma patients has c…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
This ClinicalTrials.gov update reports on a completed pediatric cancer trial evaluating dactinomycin and vincristine.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results po…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma [Phase 1]
A Phase 1 trial evaluating decitabine followed by a cancer antigen vaccine in neuroblastoma and various sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma [Phase 2]
Phase 2 trial evaluating vinorelbine tartrate and cyclophosphamide with either bevacizumab or temsirolimus in recurrent or refractory rhabdo…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
The Children's Oncology Group completed a trial update analyzing biomarkers in tumor tissue from younger patients with rhabdomyosarcoma, inc…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
This completed clinical trial update reports on biomarker analyses performed on tumor tissue samples from patients with rhabdomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Biomarkers in Patients With Rhabdomyosarcoma
A completed study investigating biomarkers in patients with rhabdomyosarcoma is reported.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
A completed clinical trial update focusing on biomarkers in samples from patients with rhabdomyosarcoma, conducted by the Children's Oncolog…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma [Phase 1]
This Phase 1 study reports on the pharmacokinetics and pharmacodynamics of XM22 in pediatric patients with Ewing sarcoma or rhabdomyosarcoma…
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Biomarkers in Patients With Advanced Rhabdomyosarcoma
This completed clinical trial explored biomarkers in patients with advanced rhabdomyosarcoma.
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
A completed clinical trial update examining genetic studies in samples from pediatric patients with rhabdomyosarcoma.